Adherence in Acute Coronary Syndrome

Published Online: Monday, March 25, 2013
Follow Pharmacy_Times:
In this video, from AJMCtv, Jeffrey Berger, MD, assistant professor at NYU Langone Medical Center, discusses how research can help increase adherence to therapies among acute coronary syndrome (ACS) patients.

Related Articles
This Continuing Education activity is supported by educational grants from AstraZeneca LP and Boehringer Ingelheim Pharmaceuticals, Inc.
Tom Frank, PharmD, BCPS, Director of Research and Education at Area Health Education Center, discusses actions that health-system pharmacists can take to better support patient medication adherence.
Various pharmacy segments have recently been focusing their attention on what they can do to reduce avoidable readmissions of patients to hospitals, including improving the discharge process.
FDA officials have recommended approval for Amgen’s proposed cholesterol-lowering medication, evolocumab (Repatha).
Latest Issues
$auto_registration$